UCD0120

UCD0120
Clinical data
Other namesUCD0120; UCD-0120; "Compound 160a"; des-B-des-C-LSD; Dides-B,C-LSD; 1-Deaza-2,3,4-trinor-LSD; DEMPDHPCA
Drug classSerotonin 5-HT2 receptor agonist; Simplified/partial LSD analogue
ATC code
  • None
Identifiers
  • N,N-diethyl-1-methyl-5-phenyl-3,6-dihydro-2H-pyridine-3-carboxamide
PubChem CID
Chemical and physical data
FormulaC17H24N2O
Molar mass272.392 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)C1CN(CC(=C1)C2=CC=CC=C2)C
  • InChI=1S/C17H24N2O/c1-4-19(5-2)17(20)16-11-15(12-18(3)13-16)14-9-7-6-8-10-14/h6-11,16H,4-5,12-13H2,1-3H3
  • Key:DRQYLJPWAXRRHI-UHFFFAOYSA-N

UCD0120, also known as dides-B,C-LSD or as 1-deaza-2,3,4-trinor-LSD, is a serotonin 5-HT2 receptor agonist and a cyclized phenethylamine and simplified or partial ergoline that is structurally related to the serotonergic psychedelic lysergic acid diethylamide (LSD). It is the analogue of LSD in which the carbon and nitrogen atoms at positions 1 through 4 of the ergoline ring system have been removed.